Biocon Limited logo

Biocon Limited

NSE:BIOCON.NS

Overview | Financials
Company Name Biocon Limited
Symbol BIOCON.NS
Currency INR
Price 321.3
Market Cap 385,752,780,000
Dividend Yield 0.48%
52-week-range 222.55 - 395.8
Industry Biotechnology
Sector Healthcare
CEO Mr. Siddharth Mittal BCom, CA, CPA
Website https://www.biocon.com

An error occurred while fetching data.

About Biocon Limited

Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and

Related Stocks

Abbott India Limited logo

Abbott India Limited

ABBOTINDIA.NS

28,553.1 INR

Zydus Lifesciences Limited logo

Zydus Lifesciences Limited

ZYDUSLIFE.NS

970.35 INR

Alkem Laboratories Limited logo

Alkem Laboratories Limited

ALKEM.NS

5,706.5 INR

Torrent Pharmaceuticals Limited logo

Torrent Pharmaceuticals Limited

TORNTPHARM.NS

3,199.85 INR

Piramal Enterprises Limited logo

Piramal Enterprises Limited

PEL.NS

1,047.65 INR

Max Healthcare Institute Limited logo

Max Healthcare Institute Limited

MAXHEALTH.NS

1,079.25 INR

Gland Pharma Limited logo

Gland Pharma Limited

GLAND.NS

1,777.6 INR

Aurobindo Pharma Limited logo

Aurobindo Pharma Limited

AUROPHARMA.NS

1,327.55 INR

Laurus Labs Limited logo

Laurus Labs Limited

LAURUSLABS.NS

499.35 INR

Apollo Hospitals Enterprise Limited logo

Apollo Hospitals Enterprise Limited

APOLLOHOSP.NS

7,421.4 INR

Financials

Numbers are in millions USD

Numbers are in millions USD